Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
151,803,139
-
Total 13F shares
-
96,113,163
-
Share change
-
+10,142,910
-
Total reported value
-
$2,669,688,515
-
Put/Call ratio
-
168%
-
Price per share
-
$27.78
-
Number of holders
-
141
-
Value change
-
+$277,820,131
-
Number of buys
-
102
-
Number of sells
-
46
Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q1 2020
As of 31 Mar 2020,
Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,113,163 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, Matrix Capital Management Company, LP, BlackRock Inc., VANGUARD GROUP INC, Senator Investment Group LP, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, GILDER GAGNON HOWE & CO LLC, Artisan Partners Limited Partnership, and TimesSquare Capital Management, LLC.
This page lists
142
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.